Literature DB >> 8618017

Detection of telomerase activity in malignant and nonmalignant skin conditions.

R S Taylor1, R D Ramirez, M Ogoshi, M Chaffins, M A Piatyszek, J W Shay.   

Abstract

Telomeres are the end regions of linear chromosomes, and in normal somatic cells the lengths of telomeres shorten with successive cell divisions. Telomerase, a ribonucleoprotein enzyme, maintains the length of telomeres in immortal and germline cells. Although present in human fetal tissues, shortly after birth telomerase activity is not detectable except in germline cells, hematopoietic cells, and most human primary tumors. In the present study we show telomerase activity to be present in 73 of 77 basal cell carcinomas, 15 of 18 nonmetastatic cutaneous squamous cell carcinomas, and 6 of 7 cutaneous melanomas, contrasting with extremely low levels detected in sun-protected skin. Sun-damaged skin, psoriatic lesional skin, and skin from lesions of poison ivy dermatitis, however, have increased levels of telomerase activity compared to sun-protected skin, although less than that detected in tumor tissue. Because telomerase activity can be found in inflammatory lesions of the skin, this indicates that telomerase activity does not always correlate with the malignant phenotype. In addition, we show that telomerase activity is localized to the epidermis of newborn foreskin, which suggests that telomerase is expressed constitutively by cells in the epidermis. Finding higher levels of telomerase activity in sun-exposed skin compared to nonexposed skin suggests that environmental factors may modulate telomerase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8618017     DOI: 10.1111/1523-1747.ep12345811

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  43 in total

1.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

2.  A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol.

Authors:  M Hirose; J Abe-Hashimoto; K Ogura; H Tahara; T Ide; T Yoshimura
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  How long should telomeres be?

Authors:  A Aviv; C B Harley
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 4.  The role of telomerase expression and telomere length maintenance in human and mouse.

Authors:  N P Weng; R J Hodes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

5.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Authors:  R D Ramirez; S D'Atri; E Pagani; T Faraggiana; P M Lacal; R S Taylor; J W Shay
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

6.  Telomerase expression in uveal melanoma.

Authors:  B Heine; S E Coupland; S Kneiff; G Demel; N Bornfeld; M Hummel; H Stein
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

7.  Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.

Authors:  C O'Flatharta; M Leader; E Kay; S R Flint; M Toner; W Robertson; M J E M F Mabruk
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

8.  Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.

Authors:  Christina Y Soohoo; Rong Shi; Tae Ho Lee; Pengyu Huang; Kun Ping Lu; Xiao Zhen Zhou
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

9.  Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues.

Authors:  E Hiyama; K Hiyama; T Yokoyama; J W Shay
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

10.  [Skin aging].

Authors:  E Kohl; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.